Connect with us
MARE BALTICUM Gaming & TECH Summit 2024

Artificial Intelligence

Glomerulonephritis Market Growing Significantly, Assesses DelveInsight | Otsuka Pharmaceutical, Chinook Therapeutics, Genentech, AstraZeneca, Novartis, Alexion, Vera Therapeutics, and Others Expected to Boost Glomerulonephritis Market

Published

on

<!– Name:DistributionId Value:8824774 –> <!– Name:EnableQuoteCarouselOnPnr Value:False –> <!– Name:IcbCode Value: –> <!– Name:CustomerId Value:1204938 –> <!– Name:HasMediaSnippet Value:false –> <!– Name:AnalyticsTrackingId Value:6f77fe66-9f1d-425c-9d40-644505ad2614 –>

New York, USA, April 25, 2023 (GLOBE NEWSWIRE) — Glomerulonephritis Market Growing Significantly, Assesses DelveInsight | Otsuka Pharmaceutical, Chinook Therapeutics, Genentech, AstraZeneca, Novartis, Alexion, Vera Therapeutics, and Others Expected to Boost Glomerulonephritis Market

The glomerulonephritis market dynamics are expected to change in the coming years owing to the rising awareness of the disease and incremental healthcare spending worldwide. In addition, the anticipated launch of emerging therapies will also boost the glomerulonephritis market during the forecast period (2023–2032).

DelveInsight’s Glomerulonephritis Market Insights report includes a comprehensive understanding of current treatment practices, glomerulonephritis emerging drugs, market share of individual therapies, and current and forecasted market size from 2019 to 2032, segmented into 7MM [the United States, the EU-4 (Italy, Spain, France, and Germany), the United Kingdom, and Japan].

Key Takeaways from the Glomerulonephritis Market Report

  • DelveInsight analysis shows that the glomerulonephritis market is expected to grow positively due to several underline factors during the study period (2019–2032).
  • According to Wetmore et al. (2022), the period prevalence of glomerulonephritis with resultant death rates and end-stage renal disease in the United States are unknown. In this retrospective cohort study based on two US administrative datasets, the Medicare sample and the Optum Clinformatics Employer Group Health Plan (EGHP), the period prevalence per 100,000 individuals was 917 and 306 in Medicare and 52 and 70 in the health plan.
  • Leading glomerulonephritis companies such as Otsuka Pharmaceutical Development & Commercialization, Inc., ACELYRIN Inc., Apellis Pharmaceuticals, Inc, Chinook Therapeutics, Inc, Visterra, Inc., HI-Bio, Genentech, Inc., RemeGen Co., Ltd., Vera Therapeutics, Inc, Novartis, Calliditas Therapeutics, Alpine Immune Sciences, Inc., Alexion, ChemoCentryx, Boehringer Ingelheim, Travere Therapeutics, Inc., Biocon Limited, River 3 Renal Corp., AstraZeneca, and others are developing novel glomerulonephritis drugs that can be available in the glomerulonephritis market in the coming years.
  • Some of the key therapies for glomerulonephritis treatment include Sibeprenlimab, Pegcetacoplan, VB119, APL-2, Atrasentan, VIS649, Felzartamab, Obinutuzumab, Telitacicept, Atacicept, BION-1301, LNP023, Nefecon, Povetacicept, Ravulizumab, ALXN2050, CCX140-B, BI 764198, RE-021, Itolizumab, R3R01, Anifrolumab, and others.
  • Several glomerulonephritis therapies are awaiting approval, while some therapies are in the advanced stages of development. 

Discover which therapies are expected to grab the major glomerulonephritis market share @ Glomerulonephritis Market Report

Glomerulonephritis Overview

Glomerulonephritis, commonly known as nephritis or nephrotic syndrome, is a collection of disorders affecting the kidney’s glomeruli, which filter blood. Glomerulonephritis is a group of kidney illnesses marked by immune-mediated destruction to the basement membrane, mesangium, or capillary endothelium, resulting in hematuria, proteinuria, and azotemia. A variety of diseases can cause glomerulonephritis. Infections, autoimmune illnesses, vasculitis, sclerotic conditions, and other factors can all induce glomerulosclerosis. It may also be linked to cancers like gastric cancer, lung cancer, and chronic lymphocytic leukemia. The most common cause of glomerulonephritis worldwide is IgA nephropathy.

There are two forms of glomerulonephritis: acute and chronic. The acute type appears quickly, whereas the chronic form may appear slowly and without glomerulonephritis symptoms over time. It frequently results in total renal failure. The signs and glomerulonephritis symptoms differ depending on whether it is acute or chronic, as well as the reason. Hematuria, proteinuria, elevated blood pressure, edoema, frequent midnight urination, and highly bubbly or frothy urine are early indications and glomerulonephritis symptoms.

Glomerulonephritis Epidemiology Segmentation

The glomerulonephritis epidemiology section provides insights into the historical and current glomerulonephritis patient pool and forecasted trends for seven individual major countries. It helps recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders.

The glomerulonephritis market report proffers epidemiological analysis for the study period 2019–2032 in the 7MM segmented into:

  • Glomerulonephritis Prevalent Population
  • Glomerulonephritis Diagnosed Prevalent Population
  • Glomerulonephritis Gender-specific Prevalent Population
  • Glomerulonephritis Treatable Cases

Download the report to understand which factors are driving glomerulonephritis epidemiology trends @ Glomerulonephritis Epidemiological Insights

Glomerulonephritis Treatment Market 

Glomerulonephritis is a systemic condition that is mostly treated by treating the underlying cause. Primary glomerulonephritis is treated with supportive care as well as disease-modifying treatment. The outcome is primarily determined by timely intervention, which, if not performed, may result in a progressive sequence of events that causes glomerulonephritis to progress into chronic kidney disease (increasing the risk of concurrent development of cardiovascular disease), the sequence eventually culminating in end-stage renal disease (ESRD).  Glomerulonephritis treatment is divided into two categories: specific management and non-specific management. As the condition progresses into chronicity, general management is implemented along the lines of chronic renal disease. Though there are no FDA-approved medications for glomerulonephritis treatment, numerous various therapies have been investigated to treat its distinct clinical manifestations.

Angiotensin-converting enzyme (ACE) inhibitors such as captopril, lisinopril, and perindopril, as well as angiotensin receptor blockers (ARBs) such as losartan, irbesartan, and valsartan c, assist in managing blood pressure. If a bacterial infection is still present when acute glomerulonephritis is identified. If glomerulonephritis is caused by malaria, antimalarial medications may be helpful. Some autoimmune illnesses that induce glomerulonephritis are treated with corticosteroids, immune suppressants, or both. High-dose corticosteroids, Rituximab, Cytotoxic agents (e.g., cyclophosphamide), and glucocorticoids are valuable in severe post-streptococcal cases glomerulonephritis), Plasma exchange (glomerular proliferative nephritis, pauci-immune glomerulonephritis – used temporarily till chemotherapy takes effect) are recommended depending upon the disease severity and the cause.

To know more about glomerulonephritis treatment, visit @ Glomerulonephritis Treatment Drugs 

Key Glomerulonephritis Therapies and Companies

  • Sibeprenlimab: Otsuka Pharmaceutical Development & Commercialization, Inc.
  • Pegcetacoplan: Apellis Pharmaceuticals, Inc.
  • VB119: ACELYRIN Inc.
  • APL-2: Apellis Pharmaceuticals, Inc
  • Atrasentan: Chinook Therapeutics, Inc
  • VIS649: Visterra, Inc.
  • Felzartamab: HI-Bio
  • Obinutuzumab: Genentech, Inc.
  • Telitacicept: RemeGen Co., Ltd.
  • Atacicept: Vera Therapeutics, Inc
  • BION-1301: Chinook Therapeutics, Inc.
  • LNP023: Novartis
  • Nefecon: Calliditas Therapeutics
  • Povetacicept: Alpine Immune Sciences, Inc.
  • Ravulizumab: Alexion
  • ALXN2050: Alexion
  • CCX140-B: ChemoCentryx
  • BI 764198: Boehringer Ingelheim
  • RE-021: Travere Therapeutics, Inc.
  • Itolizumab: Biocon Limited
  • R3R01: River 3 Renal Corp.
  • Anifrolumab: AstraZeneca

Learn more about the FDA-approved drugs for glomerulonephritis @ Drugs for Glomerulonephritis Treatment 

Glomerulonephritis Market Dynamics

In the coming years, the glomerulonephritis market is set to change due to the rising awareness of the disease and incremental healthcare spending worldwide; this would expand the glomerulonephritis market size to enable drug manufacturers to penetrate more into the glomerulonephritis market. A better understanding of glomerulonephritis pathogenesis will also contribute to developing novel therapeutics for glomerulonephritis. Moreover, several companies and academics are collaborating to examine difficulties and identify opportunities that could influence glomerulonephritis R&D. The drugs in development are focused on novel techniques for treating/improving disease conditions. In addition, the glomerulonephritis pipeline is highly robust; many possible therapies are being studied for glomerulonephritis treatment, and it is safe to assume that the therapeutic space will substantially impact the glomerulonephritis market throughout the forecast period.

However, certain factors may affect the growth of the glomerulonephritis market. The glomerulonephritis market growth may be offset by failures and discontinuation of emerging therapies, unaffordable pricing, market access and reimbursement issues, and a shortage of healthcare specialists. In addition, the undiagnosed, unreported cases and the unawareness about the disease may also impact the glomerulonephritis market growth.

Report Metrics Details
Study Period 2019–2032
Coverage 7MM [The United States, the EU-4 (Germany, France, Italy, and Spain), the United Kingdom, and Japan]
Base Year 2019
Key Glomerulonephritis Companies Otsuka Pharmaceutical Development & Commercialization, Inc., ACELYRIN Inc., Apellis Pharmaceuticals, Inc, Chinook Therapeutics, Inc, Visterra, Inc., HI-Bio, Genentech, Inc., RemeGen Co., Ltd., Vera Therapeutics, Inc, Novartis, Calliditas Therapeutics, Alpine Immune Sciences, Inc., Alexion, ChemoCentryx, Boehringer Ingelheim, Travere Therapeutics, Inc., Biocon Limited, River 3 Renal Corp., AstraZeneca, and others
Key Glomerulonephritis Therapies Sibeprenlimab, Pegcetacoplan, VB119, APL-2, Atrasentan, VIS649, Felzartamab, Obinutuzumab, Telitacicept, Atacicept, BION-1301, LNP023, Nefecon, Povetacicept, Ravulizumab, ALXN2050, CCX140-B, BI 764198, RE-021, Itolizumab, R3R01, Anifrolumab, and others

Scope of the Glomerulonephritis Market Report

  • Therapeutic Assessment: Glomerulonephritis current marketed and emerging therapies
  • Glomerulonephritis Market Dynamics: Attribute Analysis of Emerging Glomerulonephritis Drugs
  • Competitive Intelligence Analysis: SWOT analysis and Market entry strategies
  • Unmet Needs, KOL’s views, Analyst’s views, Glomerulonephritis Market Access and Reimbursement

Discover more about glomerulonephritis drugs in development @ Glomerulonephritis Clinical Trials

Table of Contents

1. Glomerulonephritis Market Key Insights
2. Glomerulonephritis Market Report Introduction
3. Glomerulonephritis Market Overview at a Glance
4. Glomerulonephritis Market Executive Summary
5. Disease Background and Overview
6. Glomerulonephritis Treatment and Management
7. Glomerulonephritis Epidemiology and Patient Population
8. Patient Journey
9. Glomerulonephritis Marketed Drugs
10. Glomerulonephritis Emerging Drugs
11. Seven Major Glomerulonephritis Market Analysis
12. Glomerulonephritis Market Outlook
13. Potential of Current and Emerging Therapies
14. KOL Views
15. Unmet Needs
16. SWOT Analysis
17. Appendix
18. DelveInsight Capabilities
19. Disclaimer
20. About DelveInsight

Related Reports

Glomerulonephritis Pipeline

Glomerulonephritis Pipeline Insight – 2023 report provides comprehensive insights about the pipeline landscape, pipeline drug profiles, including clinical and non-clinical stage products, and the key glomerulonephritis companies, including Vera Therapeutics, Inc, Novartis, Calliditas Therapeutics, Alpine Immune Sciences, Inc., Alexion, ChemoCentryx, among others.

Glomerulonephritis Epidemiology Forecast

Glomerulonephritis Epidemiology Forecast – 2032 report delivers an in-depth understanding of the disease, historical and forecasted glomerulonephritis epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.

IgA Nephropathy Market

IgA Nephropathy Market Insights, Epidemiology, and Market Forecast – 2032 report delivers an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the market trends, market drivers, market barriers, and key IgA nephropathy companies, including Omeros Corporation, Novartis Pharmaceuticals, Chinook Therapeutics, Visterra, Alnylam Pharmaceuticals, Vera Therapeutics, RemeGen, among others.

IgA Nephropathy Pipeline

IgA Nephropathy Pipeline Insight – 2023 report provides comprehensive insights about the pipeline landscape, pipeline drug profiles, including clinical and non-clinical stage products, and the key glomerulonephritis companies, including Clarity Pharmaceuticals Ltd, Eli Lilly and Company, Laboratorio Elea Phoenix S.A., PersonGen BioTherapeutics (Suzhou) Co., Ltd., among others.

IgA Nephropathy Epidemiology Forecast

IgA Nephropathy Epidemiology Forecast – 2032 report delivers an in-depth understanding of the disease, historical and forecasted IgA nephropathy epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.

Other Trending Reports

Treatment Resistant Depression Market | Advanced Renal Cell Carcinoma Market | Glomerulonephritis Market | Centronuclear Myopathy Market | Head And Neck Squamous Cell Carcinoma Market | Acquired Immunodeficiency Syndrome Market | Acute Intermittent Porphyria Market | Neurovascular Devices Market | Defibrillators Market | Ventricular Hypertrophy Market | Urolithiasis Market | Alopecia Areata Market | Autonomic Dysfunction Market | Acute Ischemic Stroke Ais Market | Adenoid Cystic Carcinoma Market | Aspergillosis Market | Biliary Atresia Market | Biliary Tumor Market | Chronic Inducible Urticaria Market | Chronic Insomnia Market | Critical Limb Ischemia Market | Endometriosis Pain Market | Generalized Anxiety Disorder Gad Market | Hallux Valgus Market | Hemophilia B Market | Immunologic Deficiency Syndrome Market | Neuromodulation Devices Market | Neurovascular Thrombectomy Devices Market | Osteosarcoma Market | Pemphigus Vulgaris Market | Progressive Familial Intrahepatic Cholestasis Market | Pruritus Market | Radiation Toxicity Market | Pulmonary Hypertension Associated With Interstitial Lung Disease Market | Cluster Headaches Market | Foot And Ankle Devices Market | Intravenous Immunoglobulin Market | Bile Duct Neoplasm Market | Blood Glucose Monitoring Systems Market | Rett Syndrome Market | Tissue Heart Valves Market | Cardiac Biomarkers Testing Devices Market | Subscription Healthcare | Hepatorenal Syndrome Market | Central Venous Catheters Market | Continuous Renal Replacement Therapy Machines Market | Nonalcoholic Steatohepatitis Market | Necrotizing Enterocolitis Market | Cardiac Amyloidosis Market | Artificial Iris Market | Aortic Aneurysm Stent Grafts Market | Polypoidal Choroidal Vasculopathy Market | Adrenal Crisis Market | Hearing Implants Market | Image Guided Surgery Devices Market | Angioedema Market | Bladder Cancer Market

Related Healthcare Services

Healthcare Consulting

Healthcare Competitive Intelligence Services

Healthcare Asset Prioritization Services

About DelveInsight

DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports pharma companies by providing comprehensive end-to-end solutions to improve their performance. Get hassle-free access to all the healthcare and pharma market research reports through our subscription-based platform PharmDelve.

Connect with us on LinkedIn|Facebook|Twitter


GlobeNewswire is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Artificial Intelligence

Cayman Enterprise City Publishes Socio-Economic Impact Assessment by Economist and Leading Advisor on the Caribbean, Marla Dukharan

Published

on

cayman-enterprise-city-publishes-socio-economic-impact-assessment-by-economist-and-leading-advisor-on-the-caribbean,-marla-dukharan

The Impact of Cayman Enterprise City’s Socio-Economic Development Project Nears USD $1 Billion
GRAND CAYMAN, Cayman Islands, May 16, 2024 /PRNewswire/ — Cayman Enterprise City (CEC) has released a Socio-Economic Impact Assessment by Marla Dukharan. The report illustrates that CEC is increasing its impact by supporting higher earnings for Caymanians and is driving a shift towards a knowledge-based economy by focusing on high productivity sectors. The release by Dukharan reads, “Caymanian resourcefulness and private sector-led innovation have been the driving force behind the islands’ outstanding socio-economic success. Cayman Enterprise City underpins the next generation of Cayman innovation and dynamism.”

With an economic impact of USD $130 million in 2023, contributing just under USD $1 billion to the local economic activity in 12 years since inception, “CEC is helping the nation to diversify economically, in terms of sectors and jobs, ensuring locals have economic and employment opportunities that match the nation’s progress,” the report reads.
The CEC socio-economic development project is now home to 352 Special Economic Zones Companies (SEZCos), many of which are globally recognised institutions led by top executives and industry experts. “CEC member companies are providing high-value employment with salaries exceeding those typically found outside of the special economic zone,” said Charlie Kirkconnell, Chief Executive Officer at CEC. “The CEC community is fully invested in Cayman and the report illustrates that the CEC socio-economic development project is making a very significant impact on Cayman’s economy and community.”
“As CEC continues to grow, it continues to create significant employment and entrepreneurial opportunities for Caymanians and we encourage anyone that might be interested in finding out how they might get involved, whether as a member of the community and/or as a volunteer in our Enterprise Cayman non-profit organisation (NPO).”
77% of Caymanian-held jobs at CEC member companies, are in sectors with high social returns and increasing global demand. “By putting skills first and prioritizing learning, CEC is enabling new industries to take root,” the release by Dukharan reads.
CEC, through its Enterprise Cayman NPO, is a first-mover in private sector-facilitated education and training in the Caribbean, making it a leading force to boost youth participation in the economy. By offering training in specialised skills, Enterprise Cayman is helping to close the gap in higher education and earnings for Caymanians. “Through Enterprise Cayman we’ve set out to strategically support meaningful employment and entrepreneurial opportunities for Caymanians, by providing internship and mentorship opportunities, by hosting skill-building and career focused training, and by providing invaluable networking and community engagement opportunities,” said Kirkconnell.
In 2023 individuals took advantage of 4,226 opportunities to participate in education, training, and career development events and, since launching entrepreneurial programming in 2021, Enterprise Cayman has worked with 41 new Cayman-born business ventures. “We’re helping to develop a local talent pool that meets the demand of Cayman’s growing digital innovation and technology sectors while, in parallel, offering exciting opportunities for individuals to launch new business ventures within an innovative business environment,” said Kirkconnell.  
With CEC’s new campus and state-of-the-art facilities, Signal House, the project “holds the promise of deep, continued economic impact,” the report concludes.
To access CEC’s economic impact assessments and Enterprise Cayman’s annual reports please visit https://www.enterprisecayman.ky/reports. For more information on how to get involved and for upcoming programmes and events visit www.enterprisecayman.ky. 
Website: www.caymanenterprisecity.com LinkedIn: @CaymanEnterpriseCityTwitter:  @CEC_CaymanInstagram: @CaymanEnterpriseCityFacebook: @CaymanEnterpriseCityYouTube: @ceccayman
About Cayman Enterprise City 
Cayman Enterprise City (CEC) is an award-winning development project which consists of three special economic zones (SEZs) focused on attracting knowledge-based and specialised-services businesses to set up a genuine physical presence in the Cayman Islands. The zones included within CEC are Cayman Tech City, Cayman Commodities & Derivatives Centre, and Cayman Maritime & Aviation City. With a dedicated Government Authority, licensing fee concessions and guaranteed fast-track processes, CEC enables international companies to quickly and efficiently establish a Cayman Islands office, which in turn enables them to generate active business income within a tax neutral environment.
About Enterprise Cayman 
Enterprise Cayman is a non-profit organisation (NPO) powered by Cayman Enterprise City in partnership with Cayman Islands’ special economic zone companies (SEZCos). The organisation, which applies the Theory of Change (TOC) methodology, provides Caymanians and residents with access to high-quality learning experiences and opportunities to develop and launch new business ventures, to pursue careers within the technology and innovation sectors, and to join a dynamic network of industry professionals. Let’s grow the next generation of Caymanian innovators and entrepreneurs with Enterprise Cayman!
Logo: https://mma.prnewswire.com/media/1317764/2860789/Cayman_Enterprise_City_Logo.jpg
FOR MORE INFORMATION:Contact: Kaitlyn Elphinstone  Email: [email protected]  

View original content:https://www.prnewswire.co.uk/news-releases/cayman-enterprise-city-publishes-socio-economic-impact-assessment-by-economist-and-leading-advisor-on-the-caribbean-marla-dukharan-302148206.html

Continue Reading

Artificial Intelligence

Strava Unveils New Chapter of Accelerated Product Development at Brand’s Flagship Event

Published

on

strava-unveils-new-chapter-of-accelerated-product-development-at-brand’s-flagship-event

The Company introduces increased product velocity, leveraging advancements in Artificial Intelligence, in service of its vision of a world connected through movement 
LOS ANGELES, May 16, 2024 /PRNewswire/ — Strava, the leading digital community for active people with more than 125 million athletes, today showcased its latest initiatives and product developments at its annual event, Camp Strava. With the theme of Progress, Together company leaders announced how the platform will empower its global community to make progress in the way they explore, move, and connect on Strava.

“Strava is gaining momentum to realize our vision of a world connected through movement,” said Michael Martin, chief executive officer of Strava. “We are focused on two fundamental shifts to accelerate how we deliver value to 125 million people globally– building for women and leveraging Artificial Intelligence – which will unlock new community-and-partner-powered experiences across the platform.”
A New Era of Product VelocityStrava, with new leaders at the helm, is ushering in its next era of product velocity. The company listened closely to feedback from its global community and announced three of the most requested features coming to the platform by the end of the year.
The first of these updates, AI-enabled Leaderboard Integrity, will harness machine learning to automatically flag irregular, improbable, or impossible activities recorded to the platform. Trained by millions of activities, this feature allows all users on Strava to play fair and have more fun.
Additionally, the company announced a new Family Plan Subscription, the sister of the company’s Student Plan. With Family Plan, it’s easier to make a fitness commitment with your community by sharing an annual subscription with up to three other people – friends, family, or fitness family. Launching in select countries this summer, with plans to roll out globally by the end of the year, Strava’s newest annual subscription option offers the best value for groups (up to four), with a discount off the regular subscription price for each member.
Strava also implemented an updated design system, an initiative that is integral in driving a heightened pace of product innovation at the company. Through this work, Strava announced the launch of one of the company’s most requested features, Dark mode. Dark mode will improve the in-app experience for all users, reducing eye strain and improving accessibility while they record activity or scroll through the feed. Athletes can expect a rollout later this summer with options to keep their mobile settings always dark, always light, or match their device settings.
Company leaders highlighted several other features and updates to current products like Flyover, with its next iteration offering an overlay with activity stats and off-platform sharing capabilities. The overlay is available today for Strava subscribers and an off-platform sharing option will be released later this year.
Build for Her, Build for ManyStudies show that women of all ages participate in sports at a far lower rate than men, and overall, despite wanting to be active, find less time to dedicate to an active lifestyle. As the company continues on its mission to motivate people to live their best active lives, building for women on the platform will ultimately serve everyone in the Strava community. Several new features and initiatives were announced as a part of this strategic focus, which includes:
Night Heatmaps: Night Heatmaps show only activities between sundown and sunrise – so athletes can get an idea of which roads, trails, and paths are well-trafficked after hours. Since Night Heatmaps filter for after-hours routes, it can be a helpful tool for female athletes training before sunrise and after sunset.Quick Edit: For active women, having control over what is shared with the Strava community that cheers them on – like what time a run is logged – is important. Quick Edit makes it easier to make the most common edits – like activity name, and privacy settings so you can hide your start time, your map, or other workout stats.Strive for More®: The company announced a new phase of its Strive for More® initiative, created in 2022 to promote and support women in movement and sport. Today, Strava unveiled an official partnership with media company TOGETHXR to encourage more women to watch – and play – women’s sports. As part of the partnership, Strava will also donate $100,000 to the Alex Morgan Foundation, started by co-founder of TOGETHXR, Alex Morgan, to support their mission to help girls and women find confident paths forward in sports and life.Athlete IntelligenceToday, Strava announced the start of an accelerated product roadmap, outlining how Strava will implement the latest technological enhancements in AI and machine learning, to transform the athlete experience.
One key advancement to the platform includes the company’s latest development, Athlete Intelligence. Strava is introducing its beta AI-powered feature which turns each subscriber’s training data into an easily digestible summary that contextualizes their accomplishments and fitness goals. Unlike other AI-powered training services, Strava connects with thousands of devices, wearables, and fitness apps, so an athlete’s insights can consider their entire fitness story across multiple sports and modalities.
The features shared at Camp Strava will be released on a rolling basis through the end of the year. To view the full list of product releases and further details, visit www.press.strava.com.
For more information on Strava, to create a free account, or to start a free subscription trial visit www.strava.com.
About Strava Strava is the leading digital community for active people with more than 125 million athletes, in more than 190 countries. The platform offers a holistic view of your active lifestyle, no matter where you live, which sport you love and/or what device you use. Everyone belongs on Strava when they are pursuing an active life. Join the community, find motivation and discover new experiences with a Strava subscription. 
Visit www.strava.com for more information and connect with Strava on Instagram, Twitter, Facebook, YouTube and LinkedIn.
Media Contact: [email protected]
 
Photo – https://mma.prnewswire.com/media/2413914/Darkmode_STRAVA.jpgPhoto – https://mma.prnewswire.com/media/2413915/Flyover_STRAVA.jpg Photo – https://mma.prnewswire.com/media/2413913/Athlete_Intelligence_STRAVA__INC.jpg 

View original content:https://www.prnewswire.co.uk/news-releases/strava-unveils-new-chapter-of-accelerated-product-development-at-brands-flagship-event-302147068.html

Continue Reading

Artificial Intelligence

Japan Data Center Market Investment to Reach $14.48 Billion by 2028 – Watch Out Exclusive Insight on Japan & Hong Kong Data Center Market – Arizton

Published

on

japan-data-center-market-investment-to-reach-$14.48-billion-by-2028-–-watch-out-exclusive-insight-on-japan-&-hong-kong-data-center-market-–-arizton

CHICAGO, May 16, 2024 /PRNewswire/ — Arizton publishes the latest research report on the Japan data center market and Hong Kong data center market.

The Japan Data Center Market to Witness Investments of $14.48 Billion by 2029.
Get Insights on 107 Existing Data Centers and 41 Upcoming Facilities across Japan.
The data center market in Japan is experiencing the emergence of self-built hyperscale data center facilities by major operators such as Google, Microsoft, and Amazon Web Services (AWS). This development is expected to impact the colocation market in Japan. Since these hyperscale operators store workloads in their own data center facilities, it may reduce the source of revenue generation for colocation operators.
Japan is a well-established data center market in the APAC region. The country supports investments with its macroeconomic policies and other incentives for investors. The market is witnessing several investments from local and global data center operators, further expanding its presence. Tokyo and Osaka are Japan’s major destinations for data center development, accounting for over 90% of the existing data center facilities. The government announced the offer of subsidies in Hokkaido and Kyushu for data center development and decentralize data centers from Tokyo and Osaka.
Investment Opportunities 
In October 2023, SoftBank and its subsidiary, IDC Frontier, announced the plan to develop a new data center facility in Tomakomai City, Hokkaido. The company invested around $420 million toward the project, for which it received subsidies worth $190 million from the Ministry of Economy, Trade, and Industry. In July 2023, Internet Initiative Japan (IIJ) launched its second data center building at the Shiroi data center campus in Chiba Prefecture, Greater Tokyo. Once fully built, the campus will house four data center buildings. Furthermore, the company is involved in a third expansion initiative in its Matsue City campus (which will likely go live in 2025).In June 2023, Digital Edge, in partnership with Hulic, a real estate developer, announced the start of the construction of a new data center facility, TY07, in Tokyo. The facility is expected to go online by 2025.In April 2024, GDS Services partnered with Gaw Capital to develop a new data center campus in Fuchu City, Tokyo. Both companies will jointly invest toward developing a new data center facility, with the first phase slated to go online by 2026.To Buy this Research Now, Click: https://www.arizton.com/market-reports/japan-data-center-market-investment-analysis
Existing Vs. Upcoming Data Centers
Existing Facilities in the Region (Area and Power Capacity)TokyoOsakaOther CitiesList of Upcoming Facilities in the Region (Area and Power Capacity)TokyoOsakaOther CitiesVendor Analysis
IT Infrastructure Providers: Arista Networks, Atos, Broadcom, Cisco Systems, Dell Technologies, Fujitsu, Hewlett Packard Enterprise (HPE), Hitachi Vantara, Huawei Technologies, IBM, Inspur, Lenovo, NEC, NetApp, and Oracle.
Data Center Construction Contractors & Sub-Contractors: Arup, AECOM, Daiwa House Industry, Fuji Furukawa Engineering & Construction, Hibiya Engineering, ISG, Kajima Corporation, Keihanshin Building, Linesight, MARCAI DESIGN, Meiho Facility Works, Nikken Sekkei, NTT FACILITIES, Obayashi Corporation, SHINRYO Corporation, TAISEI Corporation.
Support Infrastructure Providers: 3M, ABB, Alfa Laval, Caterpillar, Cummins, Delta Electronics, Eaton, Fuji Electric, HITEC Power Protection, Johnson Controls, Kawasaki Heavy Industries, KOHLSER-SDMO, Legrand, Mitsubishi Electric, Rittal, Rolls-Royce, Schneider Electric, STULZ, Siemens, Vertiv.
Data Center Investors: AirTrunk, Alibaba Cloud, Amazon Web Services, AT TOKYO, Colt Data Centre Services, Digital Edge, Equinix, Fujitsu, Goodman, Google, IDC Frontier, Internet Initiative Japan (IIJ), MC Digital Realty, Microsoft, NTT Communications, SCSK Corporation (NETXDC), Telehouse, Tencent Cloud, TIS INTEC Group.
New Entrants: Ada Infrastructure, Edge Centres, CyrusOne, ESR, GDS Services, Keppel Data Centres, NEXTDC, Princeton Digital Group (PDG), SC Zeus Data Center, STACK Infrastructure, ST Telemedia Global Data Centres, Vantage Data Centers, Yondr.
The Hong Kong Data Center Market will Witness Investments of $4.80 Billion by 2029.
Get Insights on 54 Existing Data Centers and 12 Upcoming Facilities across Hong Kong.
The Hong Kong data center market is booming, driven by the increasing demand for digital services. The data center investments in Hong Kong over the next two to three years are expected to remain high due to the surge in demand and the significant boost due to the advancements in AI technologies. Investors are actively investing in this market.
Hong Kong is a mature and thriving market for data center development in the APAC region. Investors find it an attractive market owing to the high internet and social media usage levels, a robust business ecosystem, and excellent connectivity through both inland and submarine cables. Additionally, the deployment of 5G technology further enhances its appeal.
Hong Kong stands out globally for the incredibly high rates of cell phone and home broadband service usage. With around 300 licensed internet service providers, there is robust competition, providing data center operators with a wide range of choices.
Hong Kong is considered an attractive destination for businesses due to various reasons. Its proximity to mainland China and its import-export relations with major markets, such as China and the US, make it easier for businesses to operate. Additionally, the market has experienced significant growth in Foreign Direct Investment (FDI), ranking after countries like the UK, the US, and China.
Investment Opportunities
In December 2023, the company completed the core and shell construction of phase-1 of the MEGA IDC data center campus. The facility has already signed lease agreements with cloud service providers and international banks for its available space. The company plans to expand the campus through phase-2 during the forecast period.In March 2023, the company launched its seventh data center facility, MEGA Gateway, in Tsuen Wan. The facility is part of its connected MEGA campus.Goodman is among the major investors in the Hong Kong market, and it is continuously expanding its data center presence. In March 2024, the company announced the construction of the new Texaco data center facility in Tsuen Wan. The facility is a brownfield construction that involved the conversion of an industrial building into a data center facility. The facility is likely to go online by 2026.Over 60% Of Future Demand to Come from Cloud Service Providers
The Hong Kong data center market has the presence of on-premises data centers operated by educational institutions, the government, and financial services such as HSBC Bank. A significant decline in on-premises data centers will occur in the next three to five years owing to the increase in digitalizing initiatives across sectors and the strong growth in demand for colocation and cloud services. In addition, most existing service providers offer managed solutions to enterprise customers, which will likely grow in the market from 2024-2029.
The market has the presence of all global cloud operators, such as Amazon Web Services (AWS), Google, Microsoft, Alibaba Cloud, Huawei Cloud, and Tencent Cloud. This will propel the demand for wholesale colocation services through these service providers’ continuous expansion initiatives. The cloud segments will likely dominate capacity take-up over the next five years. In addition, the market will witness the entry of multiple global organizations to service customers through a local presence.
To Buy this Research Now, Click: https://www.arizton.com/market-reports/hong-kong-data-center-market-size-analysis
Existing VS. Upcoming Data Centers
Existing Facilities in the Region (Area and Power Capacity)Tseung Kwan OKwai ChungTsuen WanFanlingFo TanChai WanTai PoOther LocationList of Upcoming Facilities in the Region (Area and Power Capacity)Tseung Kwan OKwai ChungTsuen WanFanlingFo TanChai WanTai PoOther LocationVendor Analysis
IT Infrastructure Providers: Arista Network, Atos, Cisco Systems, Dell Technologies, Fujitsu, Hewlett Packard Enterprise (HPE), Huawei Technologies, IBM, Inspur, Lenovo, NetApp.
Data Center Construction Contractors & Sub-Contractors: Arup, AtkinsRéalis, Aurecon, BYME Engineering, Chung Hing Engineers Group, Cundall, DSCO Group, Gammon Construction, ISG, Studio One Design.
Support Infrastructure Providers: ABB, Airedale, Caterpillar, Cummins, Delta Electronics, Eaton, Fuji Electric, KOHLER, Legrand, Mitsubishi Electric, Piller Power Systems, Rittal, Schneider Electric, Siemens, STULZ, Sumber, Vertiv.
Data Center Investors: AirTrunk, BDx, CITIC Telcom International, China Mobile International (CMI), China Unicom, Digital Realty, Equinix, ESR, GDS Services, Global Switch, Goodman, iTech Towers Data Centre Services, NTT DATA, SUNeVision Holdings (iAdvantage), Telehouse, Towngas Telecom (TGT), Vantage Data Centers.
New Entrants: Angelo Gordon and Mapletree Investments
Japan & Hong Kong Data Center Market Segmentation
IT Infrastructure
Servers
Storage Systems
Network Infrastructure
Electrical Infrastructure
UPS Systems
Generators
Transfer Switches & Switchgears
PDUs
Other Electrical Infrastructure
Mechanical Infrastructure
Cooling Systems
Rack Cabinets
Other Mechanical Infrastructure
Cooling Systems
CRAC & CRAH Units
Chiller Units
Cooling Towers, Condensers & Dry Coolers
Economizers & Evaporative Coolers
Other Cooling Units
General Construction
Core & Shell Development
Installation & Commissioning Services
Engineering & Building Design
Fire Detection & Suppression Systems
Physical Security
DCIM
Tier Standard
Tier I & Tier II
Tier III
Tier IV
Check Out Some of the Top Selling Research Reports:
Malaysia Data Center Market – Investment Analysis & Growth Opportunities 2024-2029https://www.arizton.com/market-reports/malaysia-data-center-market-size-analysis
Singapore Data Center Market – Investment Analysis & Growth Opportunities 2024-2029https://www.arizton.com/market-reports/singapore-data-center-market-size-analysis
Southeast Asia Data Center Construction Market – Industry Outlook & Forecast 2024-2029https://www.arizton.com/market-reports/southeast-asia-data-center-construction-market
Why Arizton?               
100% Customer Satisfaction               
24×7 availability – we are always there when you need us               
200+ Fortune 500 Companies trust Arizton’s report               
80% of our reports are exclusive and first in the industry               
100% more data and analysis               
1500+ reports published till date                
About Us:                                                    
Arizton Advisory and Intelligence is an innovative and quality-driven firm that offers cutting-edge research solutions to clients worldwide. We excel in providing comprehensive market intelligence reports and advisory and consulting services.                                                  
We offer comprehensive market research reports on consumer goods & retail technology, automotive and mobility, smart tech, healthcare, life sciences, industrial machinery, chemicals, materials, I.T. and media, logistics, and packaging. These reports contain detailed industry analysis, market size, share, growth drivers, and trend forecasts.                                                   
Arizton comprises a team of exuberant and well-experienced analysts who have mastered generating incisive reports. Our specialist analysts possess exemplary skills in market research. We train our team in advanced research practices, techniques, and ethics to outperform in fabricating impregnable research reports.                                                         
Contact Us                                                 Call: +1-312-235-2040                                                          +1 302 469 0707                                               Mail: [email protected]                                                 Contact Us: https://www.arizton.com/contact-us                                                 Blog: https://www.arizton.com/blog                                                 Website: https://www.arizton.com/
Logo: https://mma.prnewswire.com/media/818553/Arizton_Logo.jpg
 

View original content:https://www.prnewswire.co.uk/news-releases/japan-data-center-market-investment-to-reach-14-48-billion-by-2028–watch-out-exclusive-insight-on-japan–hong-kong-data-center-market—arizton-302147784.html

Continue Reading

Trending